APAC Healthcare Weekly (Jan 19)- Samsung Biologics, Daiichi Sankyo, Eisai, Sun Pharma, Biocon
APAC healthcare companies got approvals for new products as well as clinical trials. The companies continued with acquisitions and collaborations...
541 Views
AFT Pharmaceuticals - Softer H1 on one-offs; recovery expected in H2
AFT Pharmaceuticals reported H125 revenues of NZ$86.7m, a 3.7% y-o-y increase, albeit lower than expected due to one-off factors such as inventory...
402 Views
AFT Pharmaceuticals - 1H25 Result; No Pain, No Gain
Following a weak update three weeks ago, AFT Pharmaceuticals' (AFT) 1H25 result had few surprises and we have again materially downgraded our...
372 Views
AFT Pharmaceuticals - H125 profitability weighed down by one-offs
AFT Pharmaceuticals has released a trading update ahead of its H125 results, expecting to report a c NZ$2m operating loss for the period ending...
246 Views
AFT Pharmaceuticals - Maxigesic IV reaches the Chinese shores
AFT Pharmaceuticals has taken another major step in extending its international footprint, with the signing of an exclusive license agreement for...
352 Views